GoConqr hat ein neues Design! Sag uns, wie es dir gefällt.

Kostenlos registrieren

Quiz

RMSR Quiz 5 (Chapter 6)

silvertip83 9 Fragen 1.201 Aufrufe

Quiz starten

Fragen in diesem Quiz (9)

  1. 1Heterogeneous patient populations in clinical studies are a group of patients with a lot of similarities.
    1. ARichtig
    2. BFalsch
  2. 2The Abstract section is the best place to find the answer to the question Why was this study conducted?
    1. ARichtig
    2. BFalsch
  3. 3Who is ultimately responsible for legal issues that arise from the off-label or nonindicated use of a pharmaceutical?
    1. Athe company that manufactured the product, regardless of whether or not their claims were supported by scientific evidence
    2. Bthe FDA for approving the dissemination of information regarding these off-label uses
    3. Cthe pharmaceutical sales representatives who educated the physicians on the product’s off-label uses
    4. Dthe physicians who prescribed or recommended the product to their patients
  4. 4What is one of the differences between Phase I and Phase II clinical trials?
    1. APhase I trials are larger than Phase II trials.
    2. BPhase I trials are on animals, whereas Phase II trials are on humans.
    3. CPhase I trials involve subjects who do not suffer from the product's target disease or symptoms.
    4. DPhase I trials primarily involve terminally ill patients and prisoners, whereas Phase II trials are conducted on healthy volunteers.
  5. 5Which of the following distinguishes Phase III from Phase II trials?
    1. APhase III is a post-approval phase.
    2. BPhase III trials are typically conducted at multiple sites.
    3. CPhase III trials involve fewer subjects.
    4. DPhase III trials involve safety and efficacy.
  6. 6What is one way in which Phase IV trials differ from the other three phases of clinical trials (i.e., Phase I, Phase II, and Phase III)?
    1. APhase IV is conducted after the drug has already received FDA approval.
    2. BPhase IV is the only phase in which studies are not double-blinded.
    3. CPhase IV studies cannot be published.
    4. DPhase IV studies cannot be used is medical sales representatives' sales calls.
  7. 7What would most likely be included in the Introduction section of a clinical paper on a new product?
    1. Aa description of how the subjects were selected
    2. Ban overview of comparable products
    3. Cdata on how the subjects improved after using the new product
    4. Dthe authors' opinions on how this study should affect future research on the topic
  8. 8What would most likely be included in the Methods section of a clinical paper on a new IOL?
    1. Aa table summarizing subjects' adverse reactions to the new IOL
    2. Bbackground information on the effectiveness of other types of IOLs
    3. Ceverything that another researcher would need to know in order to replicate the experiment
    4. Dthe authors' theories about why this device is more effective than other IOLs
  9. 9Which of the following statements does NOT accurately describe a difference between statistical significance and clinical importance?
    1. AA study must be statistically significant in order to be clinically important.
    2. BIt is possible for the results to be statistically insignificant, but actually have high clinical importance.
    3. CMany studies’ results are statistically significant without being clinically important.
    4. DThe authors of clinical papers are trained and encouraged to emphasize statistical significance.

Informationen

Beschreibung
Medical Sales Quiz am RMSR Quiz 5 (Chapter 6), erstellt von silvertip83 am 20/12/2013.
Sprache
English
Aufrufe
1.201
Bewertung
Noch keine Bewertungen
Bewerte dieses Quiz
Bewerte dieses Quiz

Feedback

Worum geht es?

Wie gefällt dir das neue Design?

Dein Eindruck